SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹165 Cr | ₹30 Cr | ₹96 Cr | ₹102 Cr | ₹111 Cr |
What is the latest Capital Work in Progress ratio of SUVEN PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2023 | ₹165 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹96 Cr |
Mar2020 | ₹102 Cr |
Mar2019 | ₹111 Cr |
How is Capital Work in Progress of SUVEN PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2023 | ₹165 Cr | 450.41 | |
Mar2022 | ₹30 Cr | -68.80 | |
Mar2021 | ₹96 Cr | -5.33 | |
Mar2020 | ₹102 Cr | -8.56 | |
Mar2019 | ₹111 Cr | - |
Compare Capital Work in Progress of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,472.6 Cr | 3.4% | -2.3% | 34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 3.4% |
-2.3% |
34.2% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses